A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand. [electronic resource]
Producer: 20150114Description: 170 p. digitalISSN:- 1472-6963
- Adenine -- analogs & derivatives
- Adult
- Antiviral Agents -- economics
- Cost-Benefit Analysis
- Drugs, Essential -- economics
- Female
- Health Services Research
- Hepatitis B e Antigens
- Hepatitis B, Chronic -- drug therapy
- Humans
- Lamivudine -- economics
- Male
- Markov Chains
- Models, Economic
- Organophosphonates -- economics
- Quality-Adjusted Life Years
- Tenofovir
- Thailand -- epidemiology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.